Autoimmune Diseases

Immunology·MeSH: Autoimmune Diseases

31 drugs in development·22 companies·19 clinical trials

Drug Pipeline by Phase

Phase 2(3)

Drug	Company
IGM-2644	IGM Biosciences, Inc. (IGMS)
imvotamab	IGM Biosciences, Inc. (IGMS)
kio-101	Kiora Pharmaceuticals Inc. (KPRX)

Phase 1(13)

Drug	Company
AUR200	Aurinia Pharmaceuticals Inc. (AUPH)
bms-986515	Juno Therapeutics, Inc. (JUNO)
fludarabine	Juno Therapeutics, Inc. (JUNO)
ft839	FATE THERAPEUTICS INC (FATE)
KYV-101	Filana Therapeutics Inc. (FLNA)
LCAR-AIO T cells	Legend Biotech Corp (LEGN)
LUCAR-DKS1 NK cells	Legend Biotech Corp (LEGN)
LUCAR-G79 T cells	Legend Biotech Corp (LEGN)
m230	MOMENTA PHARMACEUTICALS INC (MNTA)
mb-106	MUSTANG BIO, INC. (MBIO)
tocilizumab	Juno Therapeutics, Inc. (JUNO)
velinotamig	Cullinan Therapeutics, Inc. (CGEM)
vib7734	Viela Bio, Inc. (VIE)

Preclinical(14)

Drug	Company
adi-100	Aditxt, Inc. (ADTX)
crebankitug	Zura Bio Ltd (ZURA)
inb-600	IN8BIO, INC. (INAB)
inb-619	IN8BIO, INC. (INAB)
kros 102	Kairos Pharma, LTD. (KAPA)
KYV-201	Intellia Therapeutics, Inc. (NTLA)
lnc-001	REBUS HOLDINGS, INC. (NSPX)
phoenix auto	Phoenix Life Sciences International Limited. (PLSI)
pt001	Pandion Therapeutics, Inc. (PAND)
repurposed drug for cns cancer	Cosmos Health Inc. (COSM)
sg293	Sana Biotechnology, Inc. (SANA)
sg299	Sana Biotechnology, Inc. (SANA)
torudokimab	Zura Bio Ltd (ZURA)
vib1116	Viela Bio, Inc. (VIE)

Phase 1/Phase 2(1)

Drug	Company
XmAb564	Xencor Inc (XNCR)

BioSniper tracks 31 drugs in development for Autoimmune Diseases across 22 companies.

There are 19 clinical trials targeting Autoimmune Diseases tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.